was continued until not more than traces of o-halobenzyl alcohol
remained in the reaction mixture. The reaction mixture was cooled
to 0 °C, 0.5 M Na2CO3 (100 mL) was added, and the layers were
separated. The organic phase was washed with additional portions
of 0.5 M Na2CO3 until no trace of 1,2-cyclohexandione was left.
The organic phase was dried (MgSO4) and concentrated under
reduced pressure. The crude product was purified by silica
chromatography (ether/toluene) to give the title products.
2-(2-Bromobenzyloxy)-cyclohex-2-enone (1). The compound
was prepared according to the General Procedure for Preparation
of 2-(2-Halobenzyloxy)-2-cyclohexenones. White crystalline solid,
83% yield (5.83 g, 20.7 mmol, >95% by GC-MS), mp ) 51 °C.
1H NMR (400 MHz, CDCl3) δ 7.54-7.48 (m, 2H), 7.33-7.28 (m,
1H), 7.17-7.12 (m, 1H), 5.91 (t, J ) 4.6 Hz, 1H), 4.90 (s, 2H),
2.53 (t, J ) 6.7 Hz, 2H), 2.39 (td, J ) 6.0, 4.6 Hz, 2H), 1.96 (tt,
J ) 6.7, 6.0 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 194.2, 150.3,
136.0, 132.6, 129.4, 128.9, 127.8, 122.1, 119.8, 69.0, 39.1, 24.7,
23.1. IR (KBr) 1692 cm-1. MS m/z (relative intensity 70 eV) 253
(10), 251 (10), 202 (16), 201 (100), 173 (19), 171 (98), 170 (13),
169 (94), 90 (38), 89 (37), 63 (23), 55 (24). Anal. Calcd for C13H13-
BrO2: C, 55.54; H, 4.66. Found: C, 55.40; H, 4.56.
General Procedure for Preparation of 2-(2-Halobenzyloxy)-
cyclohex-2-enol (3 and 4). 1 (7.03 g, 25 mmol) or 2 (8.20 g, 25
mmol) was dissolved in a mixture of THF (50 mL) and methanol
(50 mL) in a 250 mL round bottomed flask and cooled to 0 °C.
NaBH4 (0.95 g, 25 mmol) was added in portions under continuous
cooling and stirring. The mixture was allowed to stir for another
10 min before 0.5 M citric acid (50 mL) was added, and finally
the mixture was concentrated to <20 mL under reduced pressure.
The remaining mixture was extracted with diethyl ether, the
combined ethereal phases were dried (MgSO4) and concentrated,
and the residue was purified by chromatography (aluminum oxide
with 6% (w/w) water added, ether/toluene eluent) to furnish the
title products.
2-(2-Bromobenzyloxy)-cyclohex-2-enol (3). The compound was
prepared according to the General Procedure for Preparation of 2-(2-
Halobenzyloxy)-2-cyclohexenol. White solid, 92% yield (6.51 g,
23.0 mmol, >95% by GC-MS), mp ) 54 °C. 1H NMR (400 MHz,
CDCl3) δ 7.56 (dd, J ) 8.0, 1.3 Hz, 1H), 7.46 (dd, J ) 7.7, 1.8
Hz, 1H), 7.32 (ddd, J ) 7.7, 7.5, 1.3 Hz, 1H), 7.17 (ddd, J ) 8.0,
7.5, 1.8 Hz, 1H), 4.86-4.84 (m, 1H), 4.81 (s, 2H), 4.26-4.24 (m,
1H), 2.42 (s, 1H), 2.20-2.10 (m, 1H), 2.08-1.99 (m, 1H), 1.92-
1.77 (m, 2H), 1.76-1.66 (m, 1H), 1.61-1.52 (m, 1H). 13C NMR
(100 MHz, CDCl3) δ 154.6, 136.7, 133.0, 129.6, 129.5, 127.8,
123.1, 98.4, 68.7, 66.7, 31.3, 24.2, 19.0. IR (thin film) 3422, 3364
cm-1. MS m/z (relative intensity 70 eV) 266 (12), 264 (12), 186
(11), 185 (18), 172 (11), 171 (100), 170 (12), 169 (93), 90 (30), 89
(34), 67 (11), 63 (14). Anal. Calcd for C13H15BrO2: C, 55.14; H,
5.34. Found: C, 55.01; H, 5.21. Compound unstable in solution.
General Procedure for Spiro-Cyclizations (Table 1). The
following chemicals were added to a thick-walled tube: Pd(OAc)2,
either as a 0.1 M stock solution (50 µL of solution containing 22.5
mg/mL Pd(OAc)2 in acetonitrile, 0.005 mmol) or as solid (11.2
mg, 0.05 mmol); tetrabutylammonium bromide (322 mg, 1 mmol)
or tetrabutylammonium hydrogen sulfate (340 mg, 1 mmol); either
of the substrates: 1 (141 mg, 0.5 mmol), 2 (164 mg, 0.5 mmol), 3
(142 mg, 0.5 mmol), 4 (165 mg, 0.5 mmol), 5 (163 mg, 0.5 mmol),
6 (186 mg, 0.5 mmol), 7 (134 mg, 0.5 mmol), or 8 (157 mg, 0.5
mmol); in entry 5 only, Ag3PO4 (84 mg, 0.2 mmol); 3 mL of solvent
and PMP (0.362 mL, 2 mmol). The reaction mixture was septum
sealed in air and magnetically stirred and heated according to
specifications. The reaction mixture was cooled, diluted (diethyl
ether) and washed with water, dried (K2CO3), and concentrated
under vacuum, and the residue was purified by chromatography
(silica, ether/isohexane mobile phase) to yield products 9-12.
3′H-Spiro[cyclohex-3-ene-1,1′-isobenzofuran]-2-one (9a). Col-
orless oil, 91% yield (91.1 mg, 0.455 mmol, Table 1, entry 3, >95%
1
by GC-MS). H NMR (400 MHz, CDCl3) δ 7.27-7.21 (m, 1H),
7.20-7.15 (m, 2H), 7.11-7.08 (m, 1H), 7.01 (dtd, J ) 10.1, 4.0,
0.7 Hz, 1H), 6.07 (dt, J ) 10.1, 2.0 Hz, 1H), 5.19 (d, J ) 12.2 Hz,
1H), 5.09 (d, J ) 12.2 Hz, 1H), 2.58 (dddd, J ) 6.7, 5.5, 4.0, 2.0
Hz, 2H), 2.31 (ddd, J ) 13.6, 5.5, 0.7 Hz, 1H), 2.25 (dtd, J )
13.6, 6.7, 5.5 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 196.2, 150.7,
140.1, 139.6, 129.0, 128.7, 127.6, 121.9, 121.7, 89.5, 73.2, 34.4,
24.5. IR (thin film) 1682 cm-1. MS m/z (relative intensity 70 eV)
200 (67), 182 (11), 133 (23), 132 (100), 131 (41), 115 (13), 104
(49), 103 (19), 90 (12), 89 (22), 78 (17), 77 (11), 63 (13), 50 (10).
Anal. Calcd for C13H12O2: C, 77.98; H, 6.04. Found: C, 77.75; H,
5.94.
Acknowledgment. We acknowledge the Swedish Research
Council, Knut and Alice Wallenberg’s Foundation, Prof. Anders
Hallberg, and Dr. Luke Odell.
Supporting Information Available: Text giving full details of
experimental procedures and spectroscopic data. This material is
JO0708487
5854 J. Org. Chem., Vol. 72, No. 15, 2007